Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis
Arne Van der Vreken(Vrije Universiteit Brussel), Eline Menu(Vrije Universiteit Brussel)
Cited by 28
Related Papers
The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells
|Oncotarget|2015|147
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
|Journal of Experimental & Clinical Cancer Research|2022|31
Stimulation of invariant natural killer T cells by α‐Galactosylceramide activates the <scp>JAK</scp>‐<scp>STAT</scp> pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model
|British Journal of Haematology|2014|14
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma
|Haematologica|2023|11
B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape
|Journal of Hematology & Oncology|2025|4